Selenium Lab Results: Normal Reference Range vs. Functional Optimal

What Selenium Actually Does

Selenium is a trace mineral the body cannot produce. It gets incorporated into 25 known selenoproteins that regulate antioxidant defense, thyroid hormone metabolism, DNA synthesis, and immune signaling. The two most studied selenoproteins are glutathione peroxidase (GPx), which neutralizes hydrogen peroxide in cells, and selenoprotein P (SePP), which transports selenium from the liver to peripheral tissues including the brain and thyroid gland [1].

Three iodothyronine deiodinase enzymes (DIO1, DIO2, DIO3) require selenium at their active sites. Without adequate selenium, conversion of thyroxine (T4) to the active hormone triiodothyronine (T3) slows. This is why patients with Hashimoto thyroiditis who also have low selenium often present with a disproportionately low free T3 relative to their free T4 [2]. A 2020 review in Nature Reviews Endocrinology noted that "selenium is the only trace element for which there is evidence of a direct effect on thyroid hormone metabolism through its incorporation into deiodinases" [2].

The mineral also sits at the center of redox biology. GPx enzymes protect cell membranes from lipid peroxidation, and thioredoxin reductases (also selenoproteins) regenerate oxidized thioredoxin, a molecule involved in DNA repair and cell survival signaling [1].

Standard Reference Ranges: What Labs Report

Most commercial laboratories in the United States report a serum selenium reference range of approximately 70 to 150 ng/mL. Quest Diagnostics uses 63-160 ng/mL. Mayo Clinic Laboratories lists 23-190 ng/mL for whole blood selenium, a wider interval that reflects red blood cell selenium stores accumulated over weeks [3].

These ranges are population-derived. They represent the central 95% of values observed in presumably healthy adults. A result of 72 ng/mL will not trigger a flag on your lab report. But "within range" is not the same as "optimized."

The gap matters because reference ranges were not built to answer the question "at what concentration do selenoproteins reach full activity?" They were built to exclude statistical outliers. A value that falls inside the range tells you that you are not an outlier. It does not tell you whether your deiodinase enzymes or glutathione peroxidase molecules are operating at capacity [3].

Why Functional Practitioners Use a Narrower Window

Selenoprotein P concentration in plasma plateaus when serum selenium reaches approximately 100 to 125 ng/mL, according to dose-response work by Combs and colleagues at the USDA Grand Forks Human Nutrition Research Center [3]. Below that threshold, SePP continues to rise with increasing selenium intake, indicating that the transport protein has not yet saturated. Once it plateaus, additional selenium does not produce additional SePP, and the body begins excreting excess selenium through urine.

Glutathione peroxidase activity follows a similar saturation curve but plateaus at a slightly lower selenium concentration (roughly 90-100 ng/mL) [3]. Taken together, these two biomarkers define a functional window of about 100 to 130 ng/mL where both major selenoprotein systems are fully active without pushing intake toward the toxicity threshold.

A 2012 review in The Lancet by Margaret Rayman, professor of nutritional medicine at the University of Surrey, described this concept directly: "Supplementation is likely to benefit those with low status but could be detrimental to those already replete, creating a U-shaped relationship between selenium and health outcomes" [1]. That U-shaped curve is the reason a blanket "more is better" approach fails with selenium. The therapeutic window is real and relatively narrow.

Connecting Selenium to Thyroid Autoimmunity

Hashimoto thyroiditis affects roughly 5% of adults in the United States, and several randomized trials have examined whether selenium supplementation reduces thyroid peroxidase (TPO) antibody levels in these patients [4].

A 2007 trial by Negro and colleagues randomized 169 pregnant women with positive TPO antibodies to either 200 mcg/day of selenomethionine or placebo. The selenium group had significantly lower TPO antibody titers at delivery and a lower incidence of postpartum thyroiditis (28.6% vs. 48.6%, P = 0.01) [4]. A separate European meta-analysis of 16 trials (N = 1,494) found that selenium supplementation at 200 mcg/day reduced TPO antibodies by a weighted mean of 271 IU/mL compared to control after 6 months, though clinical thyroid function changes were inconsistent across studies [2].

The inconsistency is partly explained by baseline selenium status. Trials conducted in regions with adequate soil selenium (parts of the United States, Japan) show smaller antibody reductions than those in selenium-depleted regions (parts of Europe, particularly Germany and Poland) [2]. This reinforces why measuring your own level matters more than applying a population-wide recommendation.

Dr. Lutz Schomburg, a selenoprotein researcher at Charité University Medicine Berlin, has stated: "Selenium supplementation trials in thyroid autoimmunity are most likely to succeed when participants are selenium-deficient at baseline, and most likely to be null when participants already have adequate status" [5].

When to Order a Selenium Test

Selenium is not part of a standard metabolic panel or routine bloodwork. You need to request it specifically, and most insurance plans will cover it when ordered with a clinical indication. Testing makes the most sense in certain populations.

Patients with Hashimoto thyroiditis or Graves disease who have not had selenium measured should get a baseline level. Individuals on long-term parenteral nutrition are at risk because selenium is not always included in standard TPN formulations [5]. Patients who have undergone bariatric surgery (particularly Roux-en-Y gastric bypass) absorb selenium poorly from the duodenum and proximal jejunum, the primary absorption sites [5].

Geographic risk matters, too. Soil selenium varies by more than 100-fold across the United States. Parts of the Pacific Northwest and the Great Lakes region have lower soil selenium than the Great Plains [1]. Individuals eating a locally sourced diet in a low-selenium region may test lower than someone eating an identical macronutrient profile in South Dakota.

Vegans and vegetarians who avoid Brazil nuts, seafood, and organ meats (the three densest selenium sources) should consider periodic testing, especially if they also have thyroid antibodies [1].

Reading Your Results: Low, Optimal, and High

A serum selenium below 70 ng/mL is considered deficient by most laboratory standards. Values between 70 and 85 ng/mL fall within the conventional reference range but sit below the selenoprotein saturation threshold. In this zone, GPx and DIO enzymes may be partially under-saturated.

The functional target of 100 to 130 ng/mL aligns with full selenoprotein saturation and corresponds to a daily intake of roughly 75 to 120 mcg from all sources (food plus any supplements) in most adults [3]. This is above the RDA of 55 mcg/day but well below the tolerable upper intake level of 400 mcg/day set by the Institute of Medicine in 2000 [6].

Above 150 ng/mL, observational data become concerning. The SELECT trial (N = 35,533) found that selenium supplementation (200 mcg/day as selenomethionine) in men with baseline selenium above 122 ng/mL was associated with a non-significant trend toward increased prostate cancer risk, and a significant increase in type 2 diabetes incidence (hazard ratio 1.07, 95% CI 0.94-1.22 for diabetes in the full cohort, with stronger signal in the highest-baseline-selenium quartile) [7]. A 2007 analysis by Bleys and colleagues using NHANES III data (N = 8,876) found that adults with serum selenium above 160 ng/mL had a significantly higher prevalence of diabetes compared to those in the 100-120 ng/mL range (adjusted OR 1.57, 95% CI 1.16-2.13) [8].

These data do not mean selenium causes diabetes. They suggest that pushing selenium well above the saturation plateau offers no additional selenoprotein benefit and may interfere with insulin signaling through excessive selenoprotein P production, which has been shown in animal models to induce hepatic insulin resistance [8].

How to Raise Selenium Safely

If your level is below 100 ng/mL, dietary adjustment is the first step. One Brazil nut per day provides approximately 70 to 90 mcg of selenium, enough to move most mildly deficient individuals into the functional range within 8 to 12 weeks [1]. The selenium content of Brazil nuts varies by origin (Bolivian and Brazilian nuts tend to be higher than those from Peru), so consistency matters more than precision.

Other selenium-rich foods include yellowfin tuna (92 mcg per 3 oz serving), sardines (45 mcg per 3 oz), grass-fed beef liver (28 mcg per 3 oz), and eggs (15 mcg per large egg) [6].

When supplementation is warranted, selenomethionine and selenium-enriched yeast are the two best-studied forms. Selenomethionine is incorporated nonspecifically into body proteins in place of methionine, creating a selenium reserve. Sodium selenite, a less expensive inorganic form, has lower bioavailability and generates more oxidative intermediates during metabolism [1].

A typical repletion dose is 100 to 200 mcg/day of selenomethionine for 8 to 12 weeks, followed by a retest. Exceeding 200 mcg/day from supplements alone is rarely necessary and brings the total daily intake uncomfortably close to the 400 mcg upper limit once dietary selenium is included [6].

How to Lower Selenium When Levels Are Elevated

Selenium levels above 150 ng/mL in someone not taking supplements usually reflect high dietary intake. Brazil nuts are the most common culprit. Two to three Brazil nuts per day can push serum selenium above 200 ng/mL within weeks [1].

The first intervention is simple. Stop eating Brazil nuts and reduce intake of selenium-concentrated foods. Serum selenium has a half-life of roughly 100 to 120 days when stored in body proteins as selenomethionine, so levels decline slowly [3]. Repeat testing at 12 weeks after dietary change is reasonable.

Frank selenosis (clinical toxicity) occurs at sustained intakes above 800 to 1,000 mcg/day and presents with garlic breath odor, brittle nails, hair loss, peripheral neuropathy, and GI disturbances. This is rare outside of industrial exposure or supplement misuse [6]. If serum selenium exceeds 400 ng/mL with symptoms, referral to a toxicologist is appropriate.

For patients in the 150-200 ng/mL range without symptoms, reducing dietary selenium and discontinuing any selenium-containing supplements is sufficient. No chelation or pharmacologic intervention is indicated at these levels.

Monitoring: How Often to Recheck

After a supplementation or dietary change, recheck serum selenium at 8 to 12 weeks. This interval allows selenomethionine to equilibrate in tissue protein pools. Checking at 4 weeks may show a partial rise that does not reflect the final steady-state level [3].

Once a patient reaches the 100 to 130 ng/mL target, annual monitoring is sufficient unless dietary patterns change significantly or a new medication (such as proton pump inhibitors, which may reduce mineral absorption) is added.

For patients with thyroid autoimmunity who are supplementing selenium, tracking both selenium levels and TPO antibody titers on the same blood draw provides the most actionable data. A decline in TPO antibodies alongside a rise in selenium from deficient to optimal supports continued supplementation. Stable or rising antibodies despite adequate selenium levels suggest that selenium is not the primary driver of the autoimmune process in that individual, and the supplementation rationale should be reconsidered [2].

Whole blood selenium reflects longer-term status (weeks to months) because red blood cells incorporate selenomethionine during erythropoiesis and retain it for the cell's 120-day lifespan. Serum or plasma selenium reflects more recent intake (days to weeks). For routine clinical monitoring, serum selenium is adequate. Whole blood selenium adds value when evaluating chronic depletion in malabsorption patients [3].